TRIM44 could increase the activation of the AKT signaling pathway and activate ERK1/2; thus, suggesting that TRIM44 promotes EMT in ICC cells via the ERK-MAPK pathway. Here, TRIM44 is linked to intrahepatic cholangiocarcinoma.